AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

RAPID METHOD FOR SCREENING NOVEL CHEMICALS FOR USE IN CANCER THERAPY AND PREVENTION

IP Title: METHODS OF SCREENING NOVEL AGENTS FOR USE IN CANCER THERAPY AND PREVENTION

Detailed Technology Description: None

Application Date: Jul 25, 2001

Application No.: 6,746,843

Others

*Abstract: Chemotherapy is a widely used and effective form of treatment for many types of human cancers. However, a relatively small number of effective chemotherapeutic agents are available, and their use is complicated by the development of drug resistance by the tumors being treated. Currently, potential chemotherapy drugs are screened initially for their effect on the growth of human or murine tumor cells in culture. This type of screen is expensive, time consuming, and does not provide information on the mode of action of the drug. The current invention developed by researchers at University of Missouri is a method employing the model organism Dictyostelium discoideum for rapid and inexpensive screening of large numbers of compounds for their ability to damage DNA as assessed by the induction of DNA repair enzymes. Simultaneous determination of cell viability allows for the identification of novel drugs with anti-cancer activity.POTENTIAL AREAS OF APPLICATIONSØ Discover chemotherapy drugs that induce DNA damage but not DNA repairØ Discover chemotherapy drugs with no effects on DNA and DNA repairØ Discover chemotherapy potentiators that suppress DNA repairØ Discover cancer preventing drugs that induce DNA repair enzymes without damaging DNAMAIN ADVANTAGES OF INVENTIONØ Fast, simple, and inexpensiveØ Does not involve animals or animal cellsØ Provides information on mechanism of action of drugsØ Simultaneous monitoring of cell viability and induction of DNA repairSTATE OF DEVELOPMENTConcept has been tested using known cancer drugsLICENSING POTENTIALUniversity seeks licensee with potential to commercializePATENT STATUS: US patents 6,746,843 and 6,867,034TECHNOLOGY INNOVATORSHannah Alexander, Stephen AlexanderTECHNOLOGY MANAGER CONTACTHarriet F. Francis, MS, JD; francish@missouri.edu; 573-884-0374Per Stromhaug, PhD, MBA; stromhaugpe@missouri.edu; 573-884-3553

*IP Issue Date: Jun 8, 2004

*IP Publication Date: Apr 11, 2002

*Principal Investigator: Name: Hannah Alexander, Adjunct Associate Professor
Department:

Name: Stephen Alexander, Professor Emeritus of Biological Science
Department:

Country/Region: USA

For more information, please click Here